secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001628280-21-024928
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology reports record Q2 revenue $11.8M, up 17% YoY; operating income $263K
--------------------------------------------------------------------------------

- Record quarterly revenue of $11.8M, up 17% from $10.1M year ago.
- GAAP operating income of $263K vs. $7K a year ago; non-GAAP operating income $743K vs. $399K.
- Gross margin improved to 52.4% from 44.2% due to reduced outsourcing.
- Cash position $4.8M, no debt; net cash from ops $1.2M in quarter.
- R&D investment increased 39.3% to $2.3M for therapeutic target discovery.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828021024928/0001628280-21-024928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828021024928/csbr-20211213.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-024928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer